Arria, A.M.; Wish, E.D.; (2006). Nonmedical use of prescription stimulants among students. Pediatr Ann; 35(8): 565-71.
Banihabib, N.; Haghi, M.E.; Zare, S.; Farrokhi, F.; (2015). The effect of oral administrationof methylphenidate on hippocampal tissue in adult male rats, Neurosurgery Quarterly; 53: 153-161.
Barbaresi, W.; Katusic, S.; Colligan, R.; Oankratz, V.; Weber, K.; Mrazek, D.; et al. (2002). How common is attention- deficit hyperactivity disorder? Incidence in a population-based cohortin Rochester Minnesota. Arch Pediatr Adolesc Med; 156: 217-24.
Comim, C.M.; Gomes, K.M.; Réus, G.Z.; Petronilho, F.; Ferreira, G.K.; Streck, E.L.; Dal-Pizzol, F.; Quevedo, J.; (2014). Methylphenidate treatment causes oxidative stressand alters energetic metabolism in an animal model of attention-deficithyperactivity disorder, Acta Neuropsychiatr; 26: 96-103.
Dafny, N.; Yang, P.B.; (2006). The role of age, genotype, sex, and route of acute and chronic administration of methylphenidate: a review of its locomotor effects. Brain Res Bull; 68: 393-405.
Daniali, S.; Madjd, Z.; Shahbazi, A.; Niknazar, S.; Shahbazzadeh, D.; (2013). Chronic Ritalin administration during adulthood increases serotonin pool in rat medial frontal cortex. Iran Biomed J; 17(3): 134-9.
Gonçalves, J.; Baptista, S.; Martins, T.; Milhazes, N.; Borges, F.; Ribeiro, C.F.; Malva, J.O.; Silva, A.P.; (2010). Methamphetaminec¸ induced neuroinflammation andneuronal dysfunction in the mice hippocampus: preventive effect of indomethacin, Eur. J. Neurosci.; 31: 315-326.
Gopal, K.V.; Miller, B.R.; Gross, G.W.; (2007). Acute and sub-chronic functional neurotoxicity of methylphenidate on neural networks in vitro. J Neural Transm (Vienna). 114(11): 1365-75.
Graham, D.G.; (1978). Oxidative Pathways for Catecholamines in the Genesis of Neuromelanin and Cytotoxic Quinones. Mol Pharmacol; 14(4): 633-43.
Khademi, L.; Shariat V.; (2013). Prevalence of Nonmedical Use of Methylphenidate (Ritalin) in Residents of Tehran University of Medical Sciences and their Attitude toward Methylphenidate Use. Iranian Journal of Psychiatry and Clinical Psychology; 19(1): 20-27.
Louei Monfared, A.; Jaafari, A.; Sheibani M.T.; (2014). Histological and histometrical evidences for phenol immunotoxicity in mice. Comparative Clinical Pathology; 23: 529-534.
Leonard, B.E.; McCartan, D.; White, J.; King, D.J.; (2004). Methylphenidate: A review of its neuropharmacological, neuropsychological and adverse clinical effects. Hum Psychopharmaco; 19(3): 151-80.
Levin, F.R.; Kleber, H.D.; (1995). Attention-deficit hyperactivity disorder and substance abuse: relationships and implications for treatment. Harv Rev Psychiatry; 2(5): 246-58.
Manjanatha, M.G.; Shelton, S.D.; Dobrovolsky, V.N.; Shaddock, J.G.; McGarrity, L.G.; Doerge, D.R.; et al. (2008). Pharmacokinetics, dose-range, and mutagenicity studies of methylphenidate hydrochloride in B6C3F1 mice. Environ Mol Mutagen; 49(8): 585-93.
Marel Van der, K.; Bouet, V.; Meerhoff, G.F.; Freret, T.; Boulouard, M.; Dauphin, F.; Klomp, A.; Lucassen, P.J.; Homberg, J.R.; Dijkhuizen, R.M.; Reneman, L.; (2015). Effects of long-term methylphenidate treatment in adolescent and adult rats on hippocampal shape, functional connectivity and adult neurogenesis. Neuroscience; 19; 309: 243-58.
Motaghinejad, M.; Motevalian, M.; Shabab, B.; (2016). Effects of chronic treatment with methylphenidate on oxidative stress and inflammation in hippocampus of adult rats. Neurosci Lett; 21; 619: 106-13.
Namjoo, A.; Karimi, I.; Azizi, S.; Ansarinia, M.; (2011). Histopathologic effects of methadone on central nervous system of mice newborns in suckling period. J Shahrekord Univ Med Sci; 13(1): 1-8.
Rowland, A.S.; Umbach, D.M.; Catoe, K.E.; Stallone, L.; Long, S.; Rabiner, D.; et al. (2001). Studying the epidemiology of attention deficit hyperactivity disorder: screening method. Can J Psychiatry; 46: 931-40.
Sadasivan, S.; Pond, B.B.; Pani, A.K.; Qu, C.; Jiao, Y.; Smeyne, R.J.; (2012). Methylphenidate exposure induces dopamine neuron loss and activation of microglia in the basal ganglia of mice. PLoS One; 7(3): e33693.
Schachter, H.M.; Pham, B.; King, J.; Langford, S.; Moher, D.; (2001). How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. CMAJ. 27; 165(11): 1475-88.
Volkow, N.D.; Fowler, J.; Wang, G.; Ding, Y.; Gatley, S.J.; (2001). Mechanism of action of methylphenidate: insights from PET imaging studies. J Atten Disord; 6: S31-43.
)